Erespal widely used for the treatment of acute respiratory diseases, accompanied by a cough, including in patients with bronchial asthma (BA). Why appoint Erespal? The medicine helps to reduce signs of inflammation in the tissues of the respiratory system. The drug affects the inflammation mechanism, which prevents the development of dry cough (in asthma), and facilitates the transition from dry to wet cough in the short term.
The pharmacological properties of the drug form
Erespal - is a drug that affects the mechanisms of inflammation in the patient. During use of the drug decreases the synthesis of inflammatory cytokines, killer cells, tumor necrosis factor, arachidonic acid derivatives. When sufficient drug concentration in the blood, reduced synthesis of mediators of inflammation: serotonin, histamine. Due to extinction of inflammatory reaction reduced airway mucosal edema, which contributes to facilitate breathing. Along with the swelling decreases secretion of phlegm. These processes accelerate patient recovery.
The drug is manufactured as a tablet form and syrup. Erespal active component is fenspiride. In tablets it contains 80 mg Syrup 100 ml - 2 mg drug substance. syrup form is made especially for children, because the dosage used in pediatrics small. For adults and patients over 18 years of age prescribed Erespal tablets.
Areas of application of the drug
Erespal is prescribed for respiratory diseases and their complications. Drug like doctors because of its ability to reduce inflammation.
The drug indicated for:
- rhinitis, pharyngitis, laryngitis;
- tracheitis;
- bronchitis (accompanied by respiratory dysfunction);
- bronchial asthma (BA) (during the overall treatment regimen);
- respiratory manifestations (cough, loss of voice, sore throat) in patients with measles, whooping cough, influenza;
- respiratory infections with cough (simultaneously with an antibiotic);
- inflammatory disease of the middle ear, sinuses.
Erespal prescribed for acute symptoms of asthma. Bronchial asthma caused severe allergic reaction to an allergen entry into the body. Contact with the allergen to the mucous airways in blood triggers the release of cytokines, killer cells, macrophages and other immune cells. Due to these cellular structures develops an inflammatory reaction. It provokes the swelling of the bronchial mucosa which leads to narrowing of the lumen of the bronchial tree. The patient begins hypoxia. This leads to the development of shortness of breath, respiratory failure.
When assigning Erespal together with other bronchodilators (medicines, expanding bronchi) docked acute shortage of oxygen by reducing inflammatory mediators. The therapy fenspirid the patient's condition improves, goes shortness of breath, dry cough.
Bronchitis patients develop bronchospasm syndrome (often due to mucosal edema). Which also leads to respiratory failure, oxygen deficiency. Bronchitis at the initial stage of the disease the cough is dry, painful. Erespal helps reduce swelling, bronchial hyperreactivity. Coughing during use fenspirid becomes more humid.
Erespal prescribed for sinusitis. During the treatment of sinusitis conservative way (without puncture sinuses) patients should take Fenspiid for 2 weeks or more. The drug prevents inflammation, reduces swelling of mucous membranes of the sinuses. Against the background of improving drug treatment of purulent secretions outflow. When otitis reduced inflammatory response, pain goes away.
For what cough prescribe Erespal adult? Adult patients can take medicine in dry cough. Means helps to reduce the intensity of cough, eases the transition to wet. If the patient has a cough, the drug reduces the excessive secretion of mucus, accelerates ciliated bronchial epithelium. This facilitates the removal of mucus from the lungs. Adults are shown in the following application of the drug dosages: 1 tablet 3 times per day.
Use of the drug in children
Appoint Erespal children can whooping cough, flu, asthma, laryngeal stenosis. Toddlers up to 3 years of the bronchi clearance narrow, so any slight swelling provokes respiratory failure. If swelling occurs in the throat, they may suffocate. The drug reduces the swelling of the mucous membranes, prevents the development of asthma, and laryngeal stenosis.
Baby weighing less than 10 kg should be given 2-4 teaspoons per day, preferably before meals, with a child weighing more than 10 kg - 2-4 tablespoons per day. Duration of treatment course for each child selected individually by your doctor.
conclusion
Field of use fenspiride quite extensive. Erespal actively used for the treatment of respiratory pathologies in the pediatric outpatient therapy. The drug should be appointed very carefully to children under 5 years, since the probability of allergic reactions is high. In adults, the drug active is used for the treatment of cough of any nature, as Fenspiid mechanism operates exactly in the inflammatory response. Proper use of the drug increases the effectiveness of the treatment of asthma and other respiratory disorders.
sources:
Vidal: https://www.vidal.ru/drugs/eurespal__24397
GRLS: https://grls.rosminzdrav.ru/Grls_View_v2.aspx? routingGuid = 36b8dc82-c310-40eb-9c56-9e4313f8b10e & t =
Found a bug? Select it and press Ctrl + Enter
